XM does not provide services to residents of the United States of America.
C
C

Clariant


News

Alfa Laval, Ferrari NV, Swedbank

EUROPE RESEARCH ROUNDUP-Alfa Laval, Ferrari NV, Swedbank July 9 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alfa Laval, Ferrari NV and Swedbank, on Tuesday. HIGHLIGHTS * Alfa Laval ALFA.ST : JP Morgan raises target price to SEK 390 from SEK 385 * Ferrari NV RACE.MI : HSBC raises target price to EUR 385 from EUR 368 * Harworth Group Plc HWG.L : Peel Hunt raises target price to 195p from 165p * Moonpig Group MOONM.L : HSBC raises
A
A
A
B
B
B
B
B
B
C
C
C
E
E
F
H
H
I
P
P
S
V
A
A
D
S
S

Pearson, Softcat, Trelleborg

EUROPE RESEARCH ROUNDUP- Pearson, Softcat, Trelleborg July 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Pearson, Softcat and Trelleborg, on Friday. HIGHLIGHTS * Aker BP ASA AKRBP.OL : Jefferies cuts target price to NOK 340 from NOK 345 * GSK GSK.L : Citigroup cuts target price to 1900p from 2120p * Pearson PSON.L : Deutsche Bank raises target price to 1052p from 1050p * Softcat Plc SCTS.L : Jefferies cuts target price to 1,490p
A
A
B
C
C
D
D
E
E
G
I
K
N
N
P
T
T
T
V
W
A
D
Y

Adyen, AstraZeneca, Auto Trader

EUROPE RESEARCH ROUNDUP-Adyen, AstraZeneca, Auto Trader July 2 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen, AstraZeneca and Auto Trader, on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : Jefferies cuts target price to EUR 1,695 from EUR 1,821 * AstraZeneca AZN.L : Jefferies raises target price to 11,700p from 11,300p * Auto Trader AUTOA.L : Jefferies raises target price to 935p from 830p * Halma HLMA.L : HSBC raises target pri
3
A
A
A
B
C
C
C
E
E
E
G
H
R
S
S
V
A
A
A
A
A
B
N
N
S

Clariant seen rising after Berenberg starts coverage with 'buy'

BUZZ-Clariant seen rising after Berenberg starts coverage with 'buy' ** Shares in Clariant CLN.S are seen up 1.4% in Julius Baer premarket indications after Berenberg initiates the Swiss speciality chemicals firm with "buy", saying it sees "a clearer path to higher margins" ** The broker says it believes macro headwinds have masked the progress Cla
C
J
I

GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo

BUZZ-GS sees uneven recovery for European chemicals; ups Clariant, cuts Akzo ** Goldman Sachs favours consumer ingredient and gasses cos over diversified chemicals and paint makers based on pricing power, as the European chemicals sector faces an uneven recovery ** GS notes Europe's STOXX chemicals sub-index .SX4P is up 13% from its October 2023 tr
A
B
C
C
G
L
S
U
A
A

Top of the Street: Rentokil, Clariant, Bachem

BUZZ-Top of the Street: Rentokil, Clariant, Bachem A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** UBS upgrades Britain's Rentokil RTO.L to "neutral" from "sell" and raises the pest control company's PT by 22% to 480p, seeing a potential change in strategy, particularly after recent activist involvement ** Goldman Sachs raises Clariant CLN.S to "buy" from "neutral", saying the Swiss chemical group has successfully transformed into a fully downstream, spe
C
R

Bechtle AG, Centrica, Clariant AG

EUROPE RESEARCH ROUNDUP-Bechtle AG, Centrica, Clariant AG July 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bechtle AG, Centrica and Clariant AG, on Monday. HIGHLIGHTS * Akzo Nobel NV AKZO.AS : Goldman Sachs cuts to sell from neutral * Bechtle AG BC8G.DE : Exane BNP Paribas cuts to underperform from neutral * Centrica CNA.L : Berenberg raises to buy from hold * Clariant AG CLN.S : Goldman Sachs raises to buy from neutral * Fin
A
A
A
A
B
B
B
C
C
C
D
D
H
H
P
S
S
A
A
F
J

Baader's European chemicals picks for H2 as sector faces gradual recovery

BUZZ-Baader's European chemicals picks for H2 as sector faces gradual recovery ** Baader Helvea sees a gradual recovery ahead for the European chemicals sector, and says it favours speciality and special situations chemical companies over diversified ones ** Diversified and higher volume chemical stocks underwent a price correction during Q2, while
B
C
G
W

Heubach Colorants India gains after Quant Mutual Fund buys shares

BUZZ-Heubach Colorants India gains after Quant Mutual Fund buys shares ** Shares of Heubach Colorants India HEUB.NS rise as much as 19% to 558 rupees, highest since Feb. 12 ** Quant Mutual Fund bought 120,000 Heubach shares via bulk deals on Thursday, as per NSE data ** Purchases were at an avg price of 453.6 rupees, a 16% premium to Wednesday's close of 390.9 rupees ** Tradig vol on the day surges to 21x the 30-day avg ** Stock up 35% so far this week, eyes best weekly gain since Feb.
C

Asmi, Beiersdorf, SSE

EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Asmi, Beiersdorf and SSE, on Friday. HIGHLIGHTS * Arcadis NV ARDS.AS : KBC Securities raises to accumulate from buy * Asmi ASMI.AS : Berenberg raises target price to EUR 720 from EUR 640 * Beiersdorf BEIG.DE : HSBC raises target price to EUR 158 from EUR 152 * Nibe Industrier AB NIBEB.ST : HSBC cuts to hold from buy * SSE SSE.L : HS
A
B
B
C
D
E
E
I
J
L
L
S
W

Asmi, Beiersdorf, SSE

CORRECTED-EUROPE RESEARCH ROUNDUP-Asmi, Beiersdorf, SSE Corrects Greenyard NV entry to say KBC Securities raises target price to EUR 9.5 from EUR 8.5 (not 6.30) and Arcadis NV entry to say KBC Securities cuts (not raises) to 'accumulate' from 'buy'; raises target price to EUR 66 from EUR 61 (not 61.7 June 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Asmi, Beiersdorf and SSE, on Friday.
A
B
B
B
C
D
D
E
E
I
J
K
L
L
P
R
S
V
V
V
W
P
S

Swiss stocks - Factors to watch on May 31

Swiss stocks - Factors to watch on May 31 May 31 - Here are some of the main factors that may affect Swiss stocks on Friday: NOVARTIS AG NOVN.S Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies ( Full story ) The company also says phase III data confirm sustained efficacy and long-term safety Of oral remibrutinib in chronic spontaneous urticaria ( Full story ) COMPANY STATEMENTS Meyer Burger Technology AG MBTN.S - Board Of Directors Proposes Reverse Share Spli
C
N
U

Swiss stocks - Factors to watch on May 30

Swiss stocks - Factors to watch on May 30 ZURICH/GDANSK, May 30(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: UBS UBSG.S Swiss bank UBS said on Thursday it was making changes to its executive board. ( Full Story ) EX-DIVIDEND CLARIANT CLN.S - 0.42 CHF/shr dividend ECONOMY Swiss trade data for April due at 0600 GMT.
C
U
S

Ashtead Technology, DCC, Indra

EUROPE RESEARCH ROUNDUP- Ashtead Technology, DCC, Indra May 7 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Ashtead Technology, DCC and Indra, on Tuesday. HIGHLIGHTS * Ashtead Technology Holdings ATAS.L : Deutsche Bank initiates coverage with hold rating * DCC DCC.L : Deutsche Bank initiates coverage with buy rating and target price 7000p * Indra IDR.MC : Bernstein raises target price to EUR 29 from EUR 23 * Redde Northgate REDD.
A
A
A
A
A
A
B
B
B
C
C
D
D
E
A
A
A

Swiss stocks - Factors to watch on May 2

Swiss stocks - Factors to watch on May 2 ZURICH/BERLIN, May 2 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: CREDIT SUISSE South Korea's financial authorities have notified Credit Suisse AG it could face 50 billion won ($36.32 million) in fines over allegations it breached short-selling rules, South Korea's Chosun Ilbo daily reported on Thursday, citing industry sources.
A
C
L
S
S
U

Adidas, HSBC, Renishaw

EUROPE RESEARCH ROUNDUP-Adidas, HSBC, Renishaw May 1 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adidas, HSBC and Renishaw on Wednesday. HIGHLIGHTS * Adidas AG ADSGn.DE : Wedbush raises target price to EUR 233 from EUR 200 * Darktrace DARK.L : HSBC raises target price to 620p from 540p * Essity AB (Publ) ESSITYb.ST : HSBC resumes with buy rating; price target SEK 330 * HSBC HSBA.L : Berenberg raises target price to 830p from 80
A
A
A
A
B
B
B
C
C
E
E
F
F
H
H
H
K
L
M
P
R
S
S
S
T
E
G
N
S
U

Chemicals maker Clariant beats first-quarter profit expectations

UPDATE 2-Chemicals maker Clariant beats first-quarter profit expectations Adds CEO quote in paragraphs 3-4 and 11, share movement in paragraph 6, medium-term outlook in paragraph 9 April 30 (Reuters) - Swiss speciality chemicals maker Clariant CLN.S reported on Tuesday a higher-than-expected first-quarter core profit, citing steadier volumes and lower raw materials costs.
C
I

Chemicals maker Clariant beats Q1 profit expectations

Chemicals maker Clariant beats Q1 profit expectations April 30 (Reuters) - Swiss speciality chemicals maker Clariant CLN.S on Tuesday reported a higher-than-expected first-quarter core profit, citing stabilized volumes and lower pricing. The group's earnings before interest, taxes, depreciation and amortisation (EBITDA) rose 4% to 173 million Swiss francs ($189.9 million) in the quarter, above the 151 million Swiss francs expected by analysts in a company-provided poll .
C

Clariant Q1 EBITDA Up 4% To CHF 173 Million

BRIEF-Clariant Q1 EBITDA Up 4% To CHF 173 Million April 30 (Reuters) - Clariant AG CLN.S : CLARIANT DELIVERS GOOD START TO 2024 WITH IMPROVED PROFITABILITY – OUTLOOK CONFIRMED CLARIANT AG - Q1 2024 SALES DECREASED BY 6 % ORGANICALLY IN LOCAL CURRENCIES(1) TO CHF 1.014 BILLION CLARIANT AG - Q1 2024 EBITDA MARGIN IMPROVED TO 17.1 % COMPARED TO 13.9
C

Swiss stocks - Factors to watch on April 30

Swiss stocks - Factors to watch on April 30 ZURICH/BERLIN, April 30 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: LOGITECH INTERNATIONAL LOGN.S The maker of computer mice and keyboards increased its sales during its fourth quarter, the computer peripherals maker said on Tuesday, snapping two-and-a-half years of sales downturns after a pandemic-driven boom.
A
B
C
L
N
S
U



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.